Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Biocon- Biocon Biologics Enters Long-Term Commercial Collaboration With Eris Lifesciences

March 14 (Reuters) - Biocon Ltd  BION.NS :
    * BIOCON LTD - TOTAL TRANSACTION VALUE OF 12.42 BILLION
RUPEES 
    * BIOCON LTD- BIOCON BIOLOGICS ENTERS A LONG-TERM COMMERCIAL
COLLABORATION WITH ERIS LIFESCIENCES
    * BIOCON LTD- COLLABORATION WITH ERIS LIFESCIENCES TO EXPAND
PATIENT ACCESS IN INDIA
    * BIOCON LTD -  BIOCON BIOLOGICS HAS APPROVED TRANSFER OF
BUSINESSES IN RELATION TO ITS BRANDED FORMULATIONS IN INDIA TO
ERIS LIFESCIENCES
    * BIOCON LTD- AS PART OF DEAL OVER 430 EMPLOYEES ASSOCIATED
WITH
BUSINESS ARE EXPECTED TO TRANSITION TO ERIS
    * BIOCON LTD- BIOCON BIOLOGICS HAS SIGNED A 10-YEAR SUPPLY
AGREEMENT WITH ERIS, AS A PART OF THIS DEAL
    * BIOCON LTD- TRANSACTION IS EXPECTED TO COME INTO EFFECT
BEFORE
APRIL 15, 2024


 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eris Lifesciences

See all news